Results 241 to 250 of about 7,507,540 (309)
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
Systematic review and meta-analysis of the impact of time management on college students' learning outcomes. [PDF]
Liu B, Ma P, Jia F.
europepmc +1 more source
From digital sparks to performance gains: organizational resilience thrives under ESG pressure. [PDF]
Wang H, Xi L.
europepmc +1 more source
Informing Hospital Formulary Decisions in China: A Multi-Criteria Value Framework for GLP-1 Receptor Agonists. [PDF]
Jiang Y, Qin D, Lin S, Xu X, Wang H.
europepmc +1 more source
Modeling the Effects of Gap Cuts on Stand-Level Resilience in Financial and Carbon Sequestration Contexts. [PDF]
Fibich J +4 more
europepmc +1 more source
Tannery solid waste generation trend and sustainable management techniques for commercialization. [PDF]
Sarker D +5 more
europepmc +1 more source
Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring
Annals of Clinical and Translational Neurology, EarlyView.
Francesco Saccà, Ryan Pelto
wiley +1 more source

